Cornell Pochily Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.13M | Sell |
24,344
-863
| -3% | -$186K | 1.65% | 12 |
|
|
2026
Q1 | $5.48M | Sell |
25,207
-1,324
| -5% | -$294K | 1.61% | 13 |
|
|
2025
Q4 | $6.06M | Buy |
26,531
+459
| +2% | +$105K | 1.76% | 10 |
|
|
2025
Q3 | $6.04M | Sell |
26,072
-784
| -3% | -$160K | 1.8% | 9 |
|
|
2025
Q2 | $4.98M | Sell |
26,856
-61
| -0.2% | -$11.3K | 1.63% | 14 |
|
|
2025
Q1 | $5.64M | Sell |
26,917
-72
| -0.3% | -$14K | 1.98% | 10 |
|
|
2024
Q4 | $4.8M | Sell |
26,989
-316
| -1% | -$58.1K | 1.67% | 13 |
|
|
2024
Q3 | $5.39M | Sell |
27,305
-147
| -0.5% | -$27.4K | 1.87% | 10 |
|
|
2024
Q2 | $4.71M | Buy |
27,452
+1,683
| +7% | +$279K | 1.79% | 11 |
|
|
2024
Q1 | $4.69M | Sell |
25,769
-10
| -0% | -$1.72K | 1.86% | 11 |
|
|
2023
Q4 | $4M | Sell |
25,779
-21,777
| -46% | -$3.17M | 1.66% | 12 |
|
|
2023
Q3 | $7.09M | Buy |
47,556
+33
| +0.1% | +$4.84K | 3.09% | 3 |
|
|
2023
Q2 | $6.4M | Sell |
47,523
-62
| -0.1% | -$9.09K | 2.63% | 6 |
|
|
2023
Q1 | $7.58M | Sell |
47,585
-349
| -0.7% | -$53.4K | 3.25% | 3 |
|
|
2022
Q4 | $7.75M | Sell |
47,934
-176
| -0.4% | -$27K | 3.46% | 3 |
|
|
2022
Q3 | $6.46M | Sell |
48,110
-36
| -0.1% | -$5.17K | 2.83% | 5 |
|
|
2022
Q2 | $7.37M | Sell |
48,146
-456
| -0.9% | -$69.7K | 3.29% | 4 |
|
|
2022
Q1 | $7.88M | Sell |
48,602
-1,170
| -2% | -$170K | 3.07% | 4 |
|
|
2021
Q4 | $6.74M | Buy |
49,772
+56
| +0.1% | +$6.62K | 2.62% | 4 |
|
|
2021
Q3 | $5.36M | Buy |
49,716
+30
| +0.1% | +$3.43K | 2.32% | 6 |
|
|
2021
Q2 | $5.6M | Sell |
49,686
-1
| -0% | -$113 | 2.46% | 5 |
|
|
2021
Q1 | $5.38M | Sell |
49,687
-12,303
| -20% | -$1.32M | 2.58% | 5 |
|
|
2020
Q4 | $6.64M | Sell |
61,990
-437
| -0.7% | -$42K | 3.19% | 5 |
|
|
2020
Q3 | $5.47M | Sell |
62,427
-429
| -0.7% | -$40.4K | 3.14% | 5 |
|
|
2020
Q2 | $6.17M | Buy |
62,856
+301
| +0.5% | +$26.5K | 3.83% | 4 |
|
|
2020
Q1 | $4.77M | Sell |
62,555
-727
| -1% | -$61.9K | 3.53% | 4 |
|
|
2019
Q4 | $5.6M | Buy |
63,282
+697
| +1% | +$57.9K | 3.34% | 4 |
|
|
2019
Q3 | $4.74M | Sell |
62,585
-1,435
| -2% | -$98.4K | 3.03% | 5 |
|
|
2019
Q2 | $4.66K | Buy |
64,020
+218
| +0.3% | +$17.1K | 1.17% | 8 |
|
|
2019
Q1 | $5.14M | Sell |
63,802
-1,033
| -2% | -$84.5K | 3.51% | 4 |
|
|
2018
Q4 | $5.98M | Buy |
64,835
+824
| +1% | +$72.5K | 3.87% | 3 |
|
|
2018
Q3 | $6.05M | Sell |
64,011
-681
| -1% | -$64.6K | 4.1% | 4 |
|
|
2018
Q2 | $5.99M | Sell |
64,692
-697
| -1% | -$68.1K | 4.14% | 4 |
|
|
2018
Q1 | $6.19M | Sell |
65,389
-522
| -0.8% | -$57.3K | 4.38% | 4 |
|
|
2017
Q4 | $6.37M | Buy |
+65,911
| New | +$6.21M | 4.11% | 4 |
|
Other funds holding ABBV
Cornell Pochily Investment Advisors's ABBV Position: Q2 2026 in Review
Cornell Pochily Investment Advisors reduced its AbbVie (ABBV) stake by 3.4% in Q2 2026, selling an estimated $186K and leaving 24,344 shares worth $6.13M. The position accounts for 1.65% of the portfolio, ranked #12.
Cornell Pochily Investment Advisors first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. The position peaked at $7.88M in Q1 2022. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Cornell Pochily Investment Advisors held 24,344 shares of AbbVie worth $6.13M as of Q2 2026.
- Cornell Pochily Investment Advisors sold 863 AbbVie shares in Q2 2026, an estimated $186K.
- AbbVie made up 1.65% of Cornell Pochily Investment Advisors's portfolio in Q2 2026, its #12 holding.
- Cornell Pochily Investment Advisors first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
- Cornell Pochily Investment Advisors's AbbVie position peaked at $7.88M in Q1 2022.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Cornell Pochily Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.